Suchergebnisse - "Davies, Jane C"

PubPharm (275)

101

GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients : An open-label, single-arm, phase 2a study (SAPHIRA1)

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2019

von Davies, J. | Van de Steen, O. | van Koningsbruggen-Rietschel, S. | +8

102

Theranostics by testing CFTR modulators in patient-derived materials : The current status and a proposal for subjects with rare CFTR mutations

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2019

von Amaral, M. | de Boeck, K. | ECFS Strategic Planning Task Force on ‘Speeding up access to new drugs for CF’ | +7

103

Speeding up access to new drugs for CF : Considerations for clinical trial design and delivery

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2019

von Davies, J. | Drevinek, P. | Elborn, J. | +10

104

Who and why; sharing our experiences of developing a standard operating procedure (SOP) to allocate screening slots for highly competitive cystic fibrosis trials

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2019

von Dobra, R. | Scott, S. | Davies, J. | +1

105

"Fortunate are those who take the first steps"? The psychosocial impact of novel drug development

enthalten in: Paediatric respiratory reviews | 2019

von Dobra, R. | Madge, S. | Martin, I. | +3

106

Trials and tribulations : The highs and lows of running cystic fibrosis drug studies

enthalten in: Paediatric respiratory reviews | 2019

von Davies, J.

107

Longitudinal development of the airway microbiota in infants with cystic fibrosis

enthalten in: Scientific reports | 2019

von Ahmed, B. | Cox, M. | Cuthbertson, L. | +5

108

Chronic infection by controlling inflammation

enthalten in: Nature microbiology | 2019

von Filloux, A. | Davies, J.

CommentOn: Nat Microbiol. 2019 Mar;4(3):459-469. - PMID 30617346

109

VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

enthalten in: The New England journal of medicine | 2018

von Davies, J. | Moskowitz, S. | Brown, C. | +61

CommentIn: N Engl J Med. 2018 Oct 25;379(17):1671-1672. - PMID 30334694

110

Outdoor air pollution and cystic fibrosis

enthalten in: Paediatric respiratory reviews | 2018

von Brugha, R. | Edmondson, C. | Davies, J.